Celerion (H.I.G. Capital) — Celerion is a global contract research organization (CRO) specializing in early-stage clinical research, Phase I clinical trials, clinical pharmacology, and bioanalytical services that accelerate drug development from first-in-human studies through proof-of-concept. - View it on GitHub